These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8564906)
1. The use of oral ganciclovir in the treatment of cytomegalovirus retinitis in patients with AIDS. Ward-Able C; Phillips P; Tsoukas CM CMAJ; 1996 Feb; 154(3):363-8. PubMed ID: 8564906 [TBL] [Abstract][Full Text] [Related]
2. Ganciclovir evaluation in AIDS patients with cytomegalovirus retinitis: a European study of treatment patterns and resource utilization. Hardens M AIDS; 1996 Dec; 10 Suppl 4():S25-30. PubMed ID: 9110067 [TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy. Danner SA; Matheron S AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064 [TBL] [Abstract][Full Text] [Related]
4. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies. Squires KE AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065 [TBL] [Abstract][Full Text] [Related]
5. Oral ganciclovir effective for CMV. Grodeck B Posit Aware; 1995; ():9. PubMed ID: 11362580 [TBL] [Abstract][Full Text] [Related]
6. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group. AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972 [TBL] [Abstract][Full Text] [Related]
8. CMV: the other virus. Smart T GMHC Treat Issues; 1996 Mar; 10(3):10-1. PubMed ID: 11363389 [TBL] [Abstract][Full Text] [Related]
9. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721 [TBL] [Abstract][Full Text] [Related]
10. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
11. Funduscopy versus photographic assessment of cytomegalovirus retinitis progression: a clinician's perspective. Migdal C AIDS; 1996 Dec; 10 Suppl 4():S19-23. PubMed ID: 9110066 [TBL] [Abstract][Full Text] [Related]
12. Ganciclovir implants: one year later. Cadman J GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375 [TBL] [Abstract][Full Text] [Related]
13. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Balfour HH Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708 [TBL] [Abstract][Full Text] [Related]
16. Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patients. Owens RC; Ross JW Conn Med; 1996 Nov; 60(11):663-5. PubMed ID: 8979433 [No Abstract] [Full Text] [Related]
18. New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis). Woodward J STEP Perspect; 1995; 7(2):2-4. PubMed ID: 11362720 [TBL] [Abstract][Full Text] [Related]